Electroencephalography

Kernel Announces Neuroscience as a Service (NaaS) Platform

Retrieved on: 
Tuesday, May 5, 2020
Biotechnology, Networks, Health, Technology, Software, Branches of biology, Emerging technologies, Biology, Neurotechnology, Kernel, Electroencephalography, Neuroscience, Brain

Kernel today announced the availability of its Neuroscience as a Service (NaaS) platform, which enables organizations to conduct scientifically rigorous studies more quickly and easily than ever before, using Kernels world-leading, non-invasive brain recording technology.

Key Points: 
  • Kernel today announced the availability of its Neuroscience as a Service (NaaS) platform, which enables organizations to conduct scientifically rigorous studies more quickly and easily than ever before, using Kernels world-leading, non-invasive brain recording technology.
  • We can continuously measure and quantify almost everything in the universe except for our brains and minds, said Bryan Johnson, Founder and CEO of Kernel.
  • Kernel enables unparalleled neuroscience possibilities by making brain-recording technology small, low cost, and scalable, all without compromising state-of-the-art signal fidelity.
  • Whats been needed is to make room-sized, multi-million dollar machines small and easier to use than EEG, which Kernel has accomplished.

Assure Holdings Provides Business Update

Retrieved on: 
Friday, April 24, 2020
Medicine, Anesthesia, Clinical medicine, Electrodiagnosis, Electroencephalography, Intraoperative neurophysiological monitoring, Medical monitoring

DENVER, April 24, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, announced that it has continued to take proactive steps to ensure business stability through the novel coronavirus (COVID-19) pandemic.

Key Points: 
  • DENVER, April 24, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, announced that it has continued to take proactive steps to ensure business stability through the novel coronavirus (COVID-19) pandemic.
  • Assure has provided exceptional service, benefited this health insurance companys members with our clinical expertise and expects to be reimbursed for our services.
  • Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries.
  • Except as required by law, Assure does not intend, and undertakes no obligation, to update any forward-looking statements to reflect, in particular, new information or future events.

Assure Holdings Secures United States Small Business Administration Loan Under CARES Act

Retrieved on: 
Monday, April 20, 2020
Medicine, Medical specialties, Clinical medicine, Anesthesia, Electrodiagnosis, Electroencephalography, Intraoperative neurophysiological monitoring, Medical monitoring, Orthopedic surgery

DENVER, April 20, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), announced today that it has received a loan (Loan) under the United States Small Business Administration (SBA) Paycheck Protection Program (PPP) pursuant to the recently adopted Coronavirus Aid, Relief, and Economic Security Act.

Key Points: 
  • DENVER, April 20, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), announced today that it has received a loan (Loan) under the United States Small Business Administration (SBA) Paycheck Protection Program (PPP) pursuant to the recently adopted Coronavirus Aid, Relief, and Economic Security Act.
  • Assure has received a $1,210,700 unsecured PPP Loan.
  • In addition, Assure has applied to participate in other programs created for businesses by the U.S. federal government in response to the COVID-19 pandemic.
  • Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries.

Nihon Kohden Responds to Market Needs with New Premium Disposable Gold Cup EEG Electrodes to Ensure High Quality Signals During COVID-19 Pandemic

Retrieved on: 
Wednesday, April 15, 2020
Medical devices, Hospitals, Health, Radiology, Medical Supplies, Branches of biology, Neuroscience, Brain–computer interfacing, Neurophysiology, Biology, Neurotechnology, Electrophysiology, Electrodiagnosis, Electroencephalography, Electrode, Long-term video-EEG monitoring, Ear-EEG

Nihon Kohden, a U.S. market leader in precision medical products and services, today announced the release of a new Premium Disposable Gold Cup EEG Electrode to the healthcare community.

Key Points: 
  • Nihon Kohden, a U.S. market leader in precision medical products and services, today announced the release of a new Premium Disposable Gold Cup EEG Electrode to the healthcare community.
  • The disposable electroencephalogram (EEG) electrodes help healthcare workers prevent cross contamination between patients while maintaining high quality EEG signals.
  • Gold cup electrodes are preferred for EEG measurements because they offer superior recordings while limiting contaminating noise that can impede the test.
  • With the Premium Disposable Gold Cup EEG Electrodes, we can help protect both patients and healthcare providers.

Global Wearable EEG Devices Market (2018 to 2027) - Analysis and Forecasts by Channel, Application and Geography - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 14, 2020
Medical devices, Health, Branches of biology, Neuroscience, Medicine, Brain–computer interfacing, Electrophysiology, Neurophysiology, Neurotechnology, Psychiatric assessment, Electroencephalography, Draft:Wearable Medical Devices

The "Wearable EEG Devices Market to 2027 - Global Analysis and Forecasts by Channel; Application, and Geography" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Wearable EEG Devices Market to 2027 - Global Analysis and Forecasts by Channel; Application, and Geography" report has been added to ResearchAndMarkets.com's offering.
  • The global wearable EEG devices market is expected to reach US$ 1,556.35 Mn in 2027 from US$ 745.05 Mn in 2018.
  • Driving factors include growing incidences of neurovascular disorders, and significantly rising elderly population plays a vital role in the growth of the wearable EEG devices market.
  • However, the restraints like the high cost of wearable EEG devices are likely to affect the market growth in the forecasted period.

Neuroscience Study Finds Consumers Engage Most with “Hopeful” & Encouraging Messaging about COVID-19

Retrieved on: 
Thursday, April 9, 2020
Branches of biology, Neuroscience, Emerging technologies, Medicine, Neurotechnology, Brain–computer interfacing, Electroencephalography, Electrophysiology, Neurophysiology

The study used the Companys NeuroCap , a disposable EEG cap to measure brain activity, and eye-tracking software.

Key Points: 
  • The study used the Companys NeuroCap , a disposable EEG cap to measure brain activity, and eye-tracking software.
  • The results identified the most effective messaging for engaging with an audience during a crisis.
  • Using neuroscience to measure how our brains are responding to COVID-19 messaging is unique and timely, stated Michelle Adams, PhD, President of Marketing Brainology.
  • According to the research, consumers engaged most with hopeful and encouraging messaging about COVID-19.

Dymedix Diagnostics® Announces Dymedix Disposables™: Simple, Safe, DISPOSABLE Sleep Sensors

Retrieved on: 
Tuesday, April 7, 2020
Branches of biology, Articles, Materials, Ferroelectric materials, Fluoropolymers, Plastics, Thermoplastics, Organofluorides, Polyvinylidene fluoride, Electroencephalography, Disposable product, Sensor

The pandemic of 2020 has shown us in tragic realtime the urgent need for disposable sleep sensors.

Key Points: 
  • The pandemic of 2020 has shown us in tragic realtime the urgent need for disposable sleep sensors.
  • Dymedix Disposables is a comprehensive line of disposable respiratory effort, airflow, EEG, EMG and movement sensor products for the sleep and neurodiagnostic community.
  • This exclusive line of disposable sleep sensors are based on our patented technology using polyvinylidene fluoride (PVDF) which delivers very fast, and extremely reliable signals.
  • The Dymedix Disposables product line includes:
    TRIPLEPLAY DISPOSABLE PVDF AIRFLOW SENSORS Extreme sensitivity and response time.

Assure Holdings Provides COVID-19 Related Business Update

Retrieved on: 
Friday, April 3, 2020
Medicine, Medical specialties, Clinical medicine, Anesthesia, Electrodiagnosis, Electroencephalography, Intraoperative neurophysiological monitoring, Medical monitoring, Orthopedic surgery

Health and safety measures taken at Assure include:

Key Points: 
  • Health and safety measures taken at Assure include:
    Cancellation of all non-essential travel.
  • Farlinger continued, Over the past several weeks Assure has seen over a 50% decline in the number of procedures performed.
  • Assure has renewed efforts to collect on open claims initially made between the years 2016 to 2018.
  • Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries.

Brain Scientific Launches Online Store To Sell Sanitized EEG Products

Retrieved on: 
Wednesday, April 1, 2020
Branches of biology, Neuroscience, Brain–computer interfacing, Medicine, Neurotechnology, Electrophysiology, Neurophysiology, Psychiatric assessment, Electroencephalography, Medical device, Neurology, Food and Drug Administration

NEW YORK, April 01, 2020 (GLOBE NEWSWIRE) -- Brain Scientific Inc. (OTC:BRSF) (Brain Scientific or Company), a medical device and technology company offering products and solutions related to the brain including neurology, AI and machine learning, today announced the launch of their online store to sell FDA-cleared NeuroCap and NeuroEEG.

Key Points: 
  • NEW YORK, April 01, 2020 (GLOBE NEWSWIRE) -- Brain Scientific Inc. (OTC:BRSF) (Brain Scientific or Company), a medical device and technology company offering products and solutions related to the brain including neurology, AI and machine learning, today announced the launch of their online store to sell FDA-cleared NeuroCap and NeuroEEG.
  • During administration, traditional EEG procedure involve a scrub of the skin, which can expose EEG electrodes to blood and other disease-carrying bodily fluids.
  • With the recent COVID-19 outbreak, we have seen the importance of delivering sanitized healthcare products to not only the clinical setting, but also the general outpatient environment, stated Irina Nazarova, Marketing Director of Brain Scientific.
  • We launched our online store to meet the high demand for sterile hospital equipment and make our sterilized FDA-cleared EEG products accessible to practitioners.

US Intraoperative Neuromonitoring Market Analysis 2020-2024, Featuring Cadwell Industries, Medtronic Plc and NuVasive Inc. - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 24, 2020
Biotechnology, Health, Medical devices, Medicine, Anesthesia, Electrodiagnosis, Electroencephalography, Intraoperative neurophysiological monitoring, Medical monitoring, Clinical medicine, Trend

The intraoperative neuromonitoring market (IONM) in the US is poised to grow by USD 955.33 mn during 2020-2024, progressing at a CAGR of 10% during the forecast period.

Key Points: 
  • The intraoperative neuromonitoring market (IONM) in the US is poised to grow by USD 955.33 mn during 2020-2024, progressing at a CAGR of 10% during the forecast period.
  • This report provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
  • The report offers an up-to-date analysis regarding the current US market scenario, latest trends and drivers, and the overall market environment.
  • In addition, rising adoption of remote IONM is anticipated to boost the growth of the intraoperative neuromonitoring market in the US.